[Progress in the research of HBV reactivation in patients undergoing hematopoietic stem cell transplantation].
作者信息
Niu J X, Xu Y, Wu D P
机构信息
Department of Hematology, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):348-352. doi: 10.3760/cma.j.issn.0253-2727.2021.04.016.
Abstract
摘要
相似文献
1
[Progress in the research of HBV reactivation in patients undergoing hematopoietic stem cell transplantation].[造血干细胞移植患者乙肝病毒再激活的研究进展]
Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):348-352. doi: 10.3760/cma.j.issn.0253-2727.2021.04.016.
2
Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country.造血干细胞移植患者乙型肝炎病毒再激活：来自一个中部流行地区的单中心 20 年经验
Ann Hematol. 2020 Nov;99(11):2671-2677. doi: 10.1007/s00277-020-04206-z. Epub 2020 Jul 31.
3
HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea.韩国慢性乙型肝炎病毒（HBV）低复制状态感染者及HBV感染已康复者接受造血干细胞移植时的HBV再激活危险因素
Hepatol Int. 2017 Jan;11(1):87-95. doi: 10.1007/s12072-016-9747-0. Epub 2016 Jun 28.
4
Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study.乙型肝炎病毒再激活在隐匿性病毒携带者接受造血干细胞移植中的前瞻性研究。
Hepatology. 2017 May;65(5):1451-1461. doi: 10.1002/hep.29022. Epub 2017 Mar 22.
5
High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation.高乙肝病毒（HBV）DNA病毒载量是接受自体造血细胞移植的乙肝表面抗原阳性患者发生HBV再激活的最重要危险因素。
Blood. 2002 Apr 1;99(7):2324-30. doi: 10.1182/blood.v99.7.2324.
6
Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植中乙型肝炎病毒的管理。
Front Immunol. 2021 Feb 4;11:610500. doi: 10.3389/fimmu.2020.610500. eCollection 2020.
7
Efficacy of antiviral prophylaxis in HBsAg-negative, anti-HBc positive patients undergoing hematopoietic stem cell transplantation.抗病毒预防对接受造血干细胞移植的HBsAg阴性、抗HBc阳性患者的疗效。
Liver Int. 2015 Dec;35(12):2530-6. doi: 10.1111/liv.12882. Epub 2015 Jun 19.
8
Hepatitis B Virus Vaccination after Allogeneic Hematopoietic Cell Transplantation Prevents Post-Transplantation Hepatitis B Virus Reactivation.异基因造血细胞移植后乙型肝炎病毒疫苗接种可预防移植后乙型肝炎病毒再激活。
Transplant Cell Ther. 2022 Jul;28(7):402.e1-402.e5. doi: 10.1016/j.jtct.2022.04.004. Epub 2022 Apr 10.
9
Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment.日本造血干细胞移植受者中乙型肝炎病毒再激活：核苷（酸）类似物预防和治疗的疗效
Int J Mol Sci. 2014 Nov 21;15(11):21455-67. doi: 10.3390/ijms151121455.
本文引用的文献
1
A Novel Strategy for the Prevention of Hepatitis B Virus-Related Hepatitis Following Allogeneic Hematopoietic Stem Cell Transplantation from Hepatitis B Surface Antigen-Positive Donors.一种用于预防乙型肝炎病毒相关肝炎的新策略：来自乙型肝炎表面抗原阳性供者的异基因造血干细胞移植后。
Biol Blood Marrow Transplant. 2020 Sep;26(9):1719-1728. doi: 10.1016/j.bbmt.2020.05.004. Epub 2020 May 17.
2
HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review.造血干细胞移植患者中乙型肝炎病毒再激活：一篇叙述性综述。
Viruses. 2019 Nov 10;11(11):1049. doi: 10.3390/v11111049.
3
Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies.乙型肝炎病毒再激活：危险因素和当前的管理策略。
Pharmacotherapy. 2019 Dec;39(12):1190-1203. doi: 10.1002/phar.2340. Epub 2019 Nov 3.
4
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology.筛查和预防乙型肝炎再激活：介绍和免疫学。
Clin Liver Dis. 2019 Aug;23(3):487-492. doi: 10.1016/j.cld.2019.04.009. Epub 2019 Jun 6.
5
Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B.抗病毒治疗后乙型肝炎表面抗原早期清除与乙型肝炎病毒再激活患者的缓解。
Dig Dis Sci. 2019 Oct;64(10):2992-3000. doi: 10.1007/s10620-019-05614-6. Epub 2019 Apr 13.
6
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study.在世界上最大的回顾性队列研究中，过继供者免疫可预防异基因造血干细胞移植后已解决的乙型肝炎病毒再激活。
Br J Haematol. 2019 Jul;186(1):72-85. doi: 10.1111/bjh.15884. Epub 2019 Mar 28.
7
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab.拉米夫定预防治疗对缓解期感染患者异基因造血干细胞移植后接受利妥昔单抗治疗后乙型肝炎病毒再激活的疗效。
Infection. 2019 Feb;47(1):59-65. doi: 10.1007/s15010-018-1214-5. Epub 2018 Sep 19.
8
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.成人癌症相关免疫抑制患者的抗菌预防：ASCO 和 IDSA 临床实践指南更新。
J Clin Oncol. 2018 Oct 20;36(30):3043-3054. doi: 10.1200/JCO.18.00374. Epub 2018 Sep 4.
9
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.慢性乙型肝炎的预防、诊断和治疗最新进展：美国肝病研究学会2018年乙型肝炎指南
Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800.
10
HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma.HBsAg 阴性、抗 HBc 阴性患者在多发性骨髓瘤或恶性淋巴瘤自体造血干细胞移植后仍有发生乙型肝炎病毒相关肝炎的风险。
Cancer Res Treat. 2018 Oct;50(4):1121-1129. doi: 10.4143/crt.2017.329. Epub 2017 Dec 4.
Zotero 插件